<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30207098</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">2005-0399</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>29</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of gynecologic oncology</Title>                <ISOAbbreviation>J Gynecol Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle><i>BRCA1/2</i> mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea.</ArticleTitle>            <Pagination>                <MedlinePgn>e90</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3802/jgo.2018.29.e90</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We performed small-scale mutation and large genomic rearrangement (LGR) analysis of <i>BRCA1/2</i> in ovarian cancer patients to determine the prevalence and the characteristics of the mutations.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">All ovarian cancer patients who visited a single institution between September 2015 and April 2017 were included. Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and long-range polymerase chain reaction (PCR) were performed to comprehensively study <i>BRCA1/2</i>. The genetic risk models BRCAPRO, Myriad, and BOADICEA were used to evaluate the mutation analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 131 patients were enrolled. Of the 131 patients, Sanger sequencing identified 16 different <i>BRCA1/2</i> small-scale mutations in 20 patients (15.3%). Two novel nonsense mutations were detected in 2 patients with a serous borderline tumor and a large-cell neuroendocrine carcinoma. MLPA analysis of <i>BRCA1/2</i> in Sanger-negative patients revealed 2 LGRs. The LGRs accounted for 14.3% of all identified <i>BRCA1</i> mutations, and the prevalence of LGRs identified in this study was 1.8% in 111 Sanger-negative patients. The genetic risk models showed statistically significant differences between mutation carriers and non-carriers. The 2 patients with LGRs had at least one blood relative with breast or ovarian cancer.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Twenty-two (16.8%) of the unselected ovarian cancer patients had <i>BRCA1/2</i> mutations that were detected through comprehensive <i>BRCA1/2</i> genetic testing. Ovarian cancer patients with Sanger-negative results should be considered for LGR detection if they have one blood relative with breast or ovarian cancer. The detection of more <i>BRCA1/2</i> mutations in patients is important for efforts to provide targeted therapy to ovarian cancer patients.</AbstractText>                <CopyrightInformation>Copyright Â© 2018. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Do Hoon</ForeName>                    <Initials>DH</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9854-7850</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cho</LastName>                    <ForeName>Chi Heum</ForeName>                    <Initials>CH</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0437-4099</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kwon</LastName>                    <ForeName>Sun Young</ForeName>                    <Initials>SY</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8410-0185</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ryoo</LastName>                    <ForeName>Nam Hee</ForeName>                    <Initials>NH</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8383-709X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jeon</LastName>                    <ForeName>Dong Seok</ForeName>                    <Initials>DS</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8193-7801</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Wonmok</ForeName>                    <Initials>W</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0891-9375</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ha</LastName>                    <ForeName>Jung Sook</ForeName>                    <Initials>JS</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6475-4886</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu, Korea. ksksmom@dsmc.or.kr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>Keimyung University Dongsan Medical Center</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>J Gynecol Oncol</MedlineTA>            <NlmUniqueID>101483150</NlmUniqueID>            <ISSNLinking>2005-0380</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Res Notes. 2014 Jun 06;7:344</RefSource>                <PMID Version="1">24906410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Cancer. 2014 Jun;13(2):205-11</RefSource>                <PMID Version="1">24566764</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Genet. 2005 May;42(5):e31</RefSource>                <PMID Version="1">15863663</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Breast Cancer. 2017 Jun;20(2):203-207</RefSource>                <PMID Version="1">28690658</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Mutat. 2008 Jul;29(7):948-58</RefSource>                <PMID Version="1">18431737</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Sep 01;14:645</RefSource>                <PMID Version="1">25176351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gynecol Oncol. 2017 Jan;28(1):e3</RefSource>                <PMID Version="1">27670257</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2014 Jan 21;110(2):535-45</RefSource>                <PMID Version="1">24346285</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2018 Feb;148(2):375-382</RefSource>                <PMID Version="1">29233531</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Apr 1;63(7):1449-53</RefSource>                <PMID Version="1">12670888</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Jan;125(2):325-49</RefSource>                <PMID Version="1">20232141</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Hum Genet. 1998 Jan;62(1):145-58</RefSource>                <PMID Version="1">9443863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2018 Apr;15(4):4093-4096</RefSource>                <PMID Version="1">29541174</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2007 May 20;25(15):2027-34</RefSource>                <PMID Version="1">17513806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Gynaecol Oncol. 2016;37(2):244-6</RefSource>                <PMID Version="1">27172753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med Genet. 2017 Mar 28;18(1):38</RefSource>                <PMID Version="1">28351343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2017 Apr;145(1):137-141</RefSource>                <PMID Version="1">28159408</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res Treat. 2017 Apr;49(2):292-305</RefSource>                <PMID Version="1">28279062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2017 Jun 20;317(23):2402-2416</RefSource>                <PMID Version="1">28632866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2002 Mar 15;20(6):1480-90</RefSource>                <PMID Version="1">11896095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Mol Biol. 2009 Jul;32(3):437-46</RefSource>                <PMID Version="1">21637503</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Mol Genet. 2003 May 1;12(9):1055-61</RefSource>                <PMID Version="1">12700174</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Mol Biol. 2016 Apr-Jun;39(2):223-31</RefSource>                <PMID Version="1">27303907</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2011 May 1;121(2):353-7</RefSource>                <PMID Version="1">21324516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 May;151(1):157-68</RefSource>                <PMID Version="1">25863477</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol Rep. 2015 Jun 11;13:36-9</RefSource>                <PMID Version="1">26425718</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Test. 2006 Summer;10(2):104-15</RefSource>                <PMID Version="1">16792513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Apr 20;32(12):1249-55</RefSource>                <PMID Version="1">24638001</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 May;115(2):315-23</RefSource>                <PMID Version="1">18546071</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Genes</Keyword>            <Keyword MajorTopicYN="N">Korea</Keyword>            <Keyword MajorTopicYN="N">Mutation</Keyword>            <Keyword MajorTopicYN="N">Neoplasms</Keyword>            <Keyword MajorTopicYN="N">Ovary</Keyword>        </KeywordList>        <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30207098</ArticleId>            <ArticleId IdType="pii">29.e90</ArticleId>            <ArticleId IdType="doi">10.3802/jgo.2018.29.e90</ArticleId>            <ArticleId IdType="pmc">PMC6189434</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>